back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 10:49 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+72,222 vol |
72,222 | |
| Filed 2024-03-28 10:49 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:49 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-38,889 vol |
222,222 | |
| Filed 2024-03-28 10:48 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-72,222 vol |
261,111 | |
| Filed 2024-03-28 10:46 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+43,333 vol |
360,333 | |
| Filed 2024-03-28 10:45 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+117,000 vol |
317,000 | |
| Filed 2024-03-28 10:45 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
133,334 | |
| Filed 2024-03-28 10:44 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-63,000 vol |
156,667 | |
| Filed 2024-03-28 10:44 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
219,667 | |
| Filed 2024-03-28 10:44 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-117,000 vol |
263,000 | |
| Filed 2024-03-28 10:41 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+43,333 vol |
160,333 | |
| Filed 2024-03-28 10:40 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+117,000 vol |
117,000 | |
| Filed 2024-03-28 10:40 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:40 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
133,334 | |
| Filed 2024-03-28 10:39 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-63,000 vol |
156,667 | |
| Filed 2024-03-28 10:39 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
219,667 | |
| Filed 2024-03-28 10:38 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-117,000 vol |
263,000 | |
| Filed 2024-03-28 10:34 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+180,000 vol |
246,666 | |
| Filed 2024-03-28 10:34 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+66,666 vol |
66,666 | |
| Filed 2024-03-28 10:33 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:33 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-180,000 vol |
133,334 | |
| Filed 2024-03-28 10:33 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,666 vol |
313,334 | |
| Filed 2024-03-28 10:30 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+222,222 vol |
222,222 | |
| Filed 2024-03-28 10:30 Tx date 2022-08-15 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:30 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-222,222 vol |
444,445 | |
| Filed 2024-03-28 10:28 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+1,050,000 vol |
1,227,777 | |
| Filed 2024-03-28 10:28 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+177,777 vol |
177,777 | |
| Filed 2024-03-28 10:27 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:27 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,050,000 vol |
355,556 | |
| Filed 2024-03-28 10:26 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
1,405,556 | |
| Filed 2024-03-28 10:24 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+1,857,150 vol |
2,079,372 | |
| Filed 2024-03-28 10:24 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+222,222 vol |
222,222 | |
| Filed 2024-03-28 10:23 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:22 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,857,150 vol |
444,445 | |
| Filed 2024-03-28 10:22 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-222,222 vol |
2,301,595 | |
| Filed 2024-03-28 10:19 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-360,000 vol |
355,556 | |
| Filed 2024-03-28 10:19 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+360,000 vol |
537,777 | |
| Filed 2024-03-28 10:18 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+177,777 vol |
177,777 | |
| Filed 2024-03-28 10:17 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:14 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
715,556 | |
| Filed 2024-03-28 10:11 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
||
| Filed 2024-03-28 10:10 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
||
| Filed 2024-03-18 12:00 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+666,667 vol |
666,667 | |
| Filed 2024-03-18 11:59 Tx date 2022-08-15 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:58 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,050,000 vol |
1,583,333 | |
| Filed 2024-03-18 11:57 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+533,333 vol |
533,333 | |
| Filed 2024-03-18 11:57 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:55 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+180,000 vol |
380,000 | |
| Filed 2024-03-18 11:54 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2024-03-18 11:54 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:52 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+333,333 vol |
333,333 | |
| Filed 2024-03-18 11:51 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:50 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+180,000 vol |
380,000 | |
| Filed 2024-03-18 11:49 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2024-03-18 11:48 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:47 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+180,000 vol |
380,000 | |
| Filed 2024-03-18 11:46 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2024-03-18 11:45 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:44 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,857,150 vol |
2,523,817 | |
| Filed 2024-03-18 11:43 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+666,667 vol |
666,667 | |
| Filed 2024-03-18 11:42 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-18 11:40 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+360,000 vol |
893,333 | |
| Filed 2024-03-18 11:39 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+533,333 vol |
533,333 | |
| Filed 2024-03-18 11:26 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 14:54 Tx date 2023-09-11 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-100,000 vol |
200,000 | |
| Filed 2023-08-16 10:19 Tx date 2023-02-14 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
350,000 | |
| Filed 2023-08-15 15:58 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
3,200,000 | |
| Filed 2023-08-15 15:08 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+900,000 vol |
1,100,000 | |
| Filed 2023-08-15 15:06 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
775,000 | |
| Filed 2023-08-15 15:03 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
525,000 | |
| Filed 2023-08-15 15:00 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
925,000 | |
| Filed 2023-08-15 14:58 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
2,100,000 | |
| Filed 2023-08-15 14:54 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
5,495,250 | |
| Filed 2023-08-15 14:50 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
1,025,000 | |
| Filed 2023-08-09 20:14 Tx date 2023-08-03 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+565,217 vol |
1,130,434 | |
| Filed 2023-08-09 20:13 Tx date 2023-08-03 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+565,217 vol |
565,217 | |
| Filed 2023-08-09 20:11 Tx date 2023-08-03 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$259,999
+1,130,434 vol $0.23 each |
49,726,311 | |
| Filed 2023-04-16 00:13 Tx date 2023-04-13 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-100,000 vol |
300,000 | |
| Filed 2022-08-25 05:00 Tx date 2022-08-15 |
$INNO
InnoCan Pharma Corporation |
Kamhi, Roni
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2021-12-06 15:55 Tx date 2021-12-06 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-100,000 vol |
400,000 | |
| Filed 2021-09-27 04:49 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$88,500
+150,000 vol $0.59 each |
||
| Filed 2021-09-27 04:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$88,500
+150,000 vol $0.59 each |
||
| Filed 2021-09-13 05:06 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$88,500
+150,000 vol $0.59 each |
700,000 | |
| Filed 2021-09-13 05:05 Tx date 2021-03-15 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$61,499
+150,000 vol $0.41 each |
550,000 | |
| Filed 2021-09-13 05:05 Tx date 2020-07-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+100,000 vol $0.16 each |
400,000 | |
| Filed 2021-09-09 14:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
550,000 | |
| Filed 2021-09-05 20:46 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$236,000
+400,000 vol $0.59 each |
800,000 | |
| Filed 2021-09-05 20:34 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$147,500
+250,000 vol $0.59 each |
||
| Filed 2021-09-05 05:45 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$295,000
+500,000 vol $0.59 each |
2,500,000 | |
| Filed 2021-09-05 05:44 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$295,000
+500,000 vol $0.59 each |
1,300,000 | |
| Filed 2021-09-05 05:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Druker, Yoram
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$295,000
+500,000 vol $0.59 each |
2,660,000 | |
| Filed 2021-09-05 05:41 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$590,000
+1,000,000 vol $0.59 each |
4,495,250 | |
| Filed 2021-09-05 05:39 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Avram, Nir
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,000
+100,000 vol $0.59 each |
872,458 | |
| Filed 2021-08-27 20:18 Tx date 2021-08-11 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+3,888,889 vol |
48,595,877 | |
| Filed 2021-08-27 20:17 Tx date 2021-08-11 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-3,888,889 vol |
0 | |
| Filed 2021-03-02 01:01 Tx date 2021-02-22 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+10,321,282 vol |
44,706,988 | |
| Filed 2021-02-26 21:11 Tx date 2021-02-22 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+15,981,916 vol |
||
| Filed 2021-02-26 21:11 Tx date 2021-02-22 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+15,981,916 vol |
50,367,622 | |
| Filed 2021-02-26 21:10 Tx date 2021-02-22 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-15,981,916 vol |
3,888,889 | |
| Filed 2021-02-26 21:09 Tx date 2020-06-09 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+3,888,889 vol |
19,870,805 | |
| Filed 2021-02-26 21:03 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
15,981,916 | ||
| Filed 2021-02-26 14:11 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-26 14:10 Tx date 2020-06-09 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+3,888,889 vol |
||
| Filed 2021-02-26 13:54 Tx date 2020-06-09 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+3,888,889 vol |
3,888,889 | |
| Filed 2021-02-26 13:54 Tx date 2020-06-09 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+3,888,889 vol |
||
| Filed 2021-02-26 13:51 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-26 13:51 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-26 13:46 Tx date 2020-06-09 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$700,000
+3,888,889 vol $0.18 each |
34,385,706 | |
| Filed 2019-10-22 10:02 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Tamar InnoVest Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-30 12:13 Tx date 2018-09-13 |
$INNO
InnoCan Pharma Corporation |
MacDonald, William Colin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2020-06-30 12:13 Tx date 2018-09-13 |
$INNO
InnoCan Pharma Corporation |
MacDonald, William Colin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2019-09-23 10:14 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
MacDonald, William Colin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-23 10:12 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
MacDonald, William Colin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-17 08:46 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
800,000 | |
| Filed 2020-06-17 08:44 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Halpern, Nelson Harvey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
| Filed 2020-06-17 08:42 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Mayron, Ron
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
2,000,000 | |
| Filed 2020-06-17 08:37 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Druker, Yoram
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+410,000 vol |
2,160,000 | |
| Filed 2020-06-17 08:30 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
3,495,250 | |
| Filed 2020-04-30 20:51 Tx date 2020-04-19 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2020-04-30 15:56 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-29 10:00 Tx date 2020-01-29 |
$INNO
InnoCan Pharma Corporation |
MacDonald, William Colin
1 - Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+2,000 vol $0.125 each |
752,000 | |
| Filed 2020-01-13 17:41 Tx date 2020-01-09 |
$INNO
InnoCan Pharma Corporation |
Fridhandler, Daryl Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSUs
97 - Other
|
$2,000
+12,500 vol $0.16 each |
22,500 | |
| Filed 2019-11-28 11:54 Tx date 2019-11-24 |
$INNO
InnoCan Pharma Corporation |
Fridhandler, Daryl Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSUs
97 - Other
|
$3,000
+10,000 vol $0.30 each |
10,000 | |
| Filed 2019-11-28 11:48 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Fridhandler, Daryl Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSUs
00 - Opening Balance-Initial SEDI Report
|